Legend Biotech Corporation
Price Action
Technical Summary
WEAKENINGLegend Biotech Corporation is in a technical downtrend, trading below key resistance levels with a broken trend structure. Relative strength is weak (RS Rating: 46), showing significant lag compared to the market leaders. Earnings contraction of 221% provides fundamental context to the price action. However, with RSI at 77, the stock is extended and may be prone to a short-term pullback.
Trend Template (Minervini)
Price vs Moving Averages
| Period | Value | Spread | Signal |
|---|---|---|---|
| 20 SMA | $23.03 | +25.73% | ABOVE |
| 50 SMA | $20.24 | +43.05% | ABOVE |
| 100 SMA | $20.27 | +42.90% | ABOVE |
| 150 SMA | $23.67 | +22.37% | ABOVE |
| 200 SMA | $26.84 | +7.88% | ABOVE |
Price Performance
Technical Indicators
Risk Profile
Volume Analysis
Earnings Momentum
Growth Trends
Compounded Sales Growth
Compounded Profit Growth
Stock Price CAGR
Return on Equity
Key Metrics
Frequently Asked Questions
Is LEGN in an uptrend right now?
LEGN has a trend score of 1/4 based on Minervini's Stage Analysis. Currently showing broken structure - 1 of 4 trend criteria are met.
Is LEGN overbought or oversold?
LEGN's RSI (14) is 77. The stock is in overbought territory (RSI > 70), which may signal a pullback.
Is LEGN outperforming the market?
LEGN has a Relative Strength (RS) Rating of 46 out of 99. LEGN is currently lagging the broader market.
Where is LEGN in its 52-week range?
LEGN is trading at $28.96, which is 64% of its 52-week high ($45.30) and 44% above its 52-week low ($16.24).
How volatile is LEGN?
LEGN has a Beta of 0.77 and 52-week volatility of 52%. It's less volatile than the S&P 500 - generally more stable.